Taïeb, D <br/><br/>
Subcutaneous administration of recombinant human thyrotropin as an alternative to thyroid hormone withdrawal in patients with anticoagulated thyroid cancer: preliminary results.  [electronic resource] 

 -  Thyroid : official journal of the American Thyroid Association  Jun 2004 
 - 463-4 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1050-7256 
<br/><br/><label>Standard No.: </label>10.1089/105072504323150796  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Anticoagulants--therapeutic use<br/>Female<br/>Hematoma--prevention & control<br/>Humans<br/>Injections, Subcutaneous<br/>Iodine Radioisotopes--therapeutic use<br/>Male<br/>Medical Records<br/>Middle Aged<br/>Recombinant Proteins--administration & dosage<br/>Thyroglobulin--blood<br/>Thyroid Neoplasms--drug therapy<br/>Thyroidectomy--methods<br/>Thyrotropin--administration & dosage<br/>Treatment Outcome